London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Or. Given the recent volatility, they were hoping to drop the share price to 0.065HKD by trading one share...... ;-)
Maybe cos of the lock-down it means...."Wanna meet for coffee, but dont tell anyone"....LOL
One share buy or sell (doesn't say either way) at 09:35. What does that mean as its worth only 0.065HKD ???
Only the MM's would do this as it would cost much much more just to make the trade. ;-)
Secret messages, but on the wrong ticker ?.....LOL
For some unfathomable reason, UK distribution is exclusive to Doctor-4-U (and their IMed) subsidiary.
But, with D4U reduced to flogging Fortacin at £1.99 for the past month in an attempt to shift June-expiry stock, following price cuts from £59.99 down to £9.99, I suspect that Numan does not feel that it's missing out on anything. Besides, they can pick up an established OEM knob spray (manufactured in Watford, with pan-European product authorisation) for less than 50p a can.
I agree bignose . No correct date and company just spout lies on timeframes. I just want out now but to much of loss at moment . As soon as I get a bit more back hopefully by some miracle . I am out
I would suggest that instead of them harping on about modelling projections on the the ED market, they actually carry out an online survey on who would have the balls to buy the product, especially after the fiasco in the EU. At least they would have more meaningful figures than just speculative assumptions.... ;-)
So, please excuse me if I take all you have written as meaningless, which I assume came from the company... ;-)
They keep writing about the US etc, however. They certainly appear to keep dragging their feet and have no clue on timelines. One would think that if they were so confident on the US, they would spend more time in getting dates right.
As mentioned before, on the 11th March PLE announced an "FDA have unambiguously defined a path to a successful submission of the New Drug Application for PSD 502".
This is now over 6 years ago. It surely doesn't take that long to sort out phase II. Every date they have given has been wrong, the latest being the completion of phase II. ts inherent, they couldn't even get the Recordati, HK launch dates or China submission date correct. Its managements incompetence.
They also go on to state that "The Company sees a significant potential market opportunity for PSD 502 both in the United States and EU. Based on the Company's internal modeling and pricing input from its US marketing consultant, the Company forecasts in excess of US$1 billion per annum peak prescription sales. It therefore sees significant value in PSD 502 for the Company's shareholders and correspondingly, management is to looking to unlock that value as quickly as possible through bringing to closure negotiations with potential marketing partners. In this respect, the Company has received several expressions of interest for out-licensing PSD 502 in the US, EU and other territories. Negotiations are at a more advanced stage with a number of potential marketing partners and the Company is hopeful that an announcement will be made in this regard over the coming months"
Given that that was written all that time ago, where are the US license agreements? Even a Chinese license agreement has been signed, which was not even on the cards until towards the end of 2016 (no big achievement since we still have another 3 to 4 years to wait, but at least the Chinese have committed). Where is the potential in the EU which they were so confident about? They did no market research in the EU and they have done absolutely diddly squat for the US. Instead, they keep paying an incompetence salary of 8% of the current market cap to someone who doesn't deserve it.
In the PLE 11th Nov announcement of the same year (after the unambiguous FDA agreement), they stated "Clarifying and confirming the anticipated timelines relating to the NDA filing and potential approval of FORTACIN™ in the US. The Company expects to complete the filing of the FORTACIN™ NDA incorporating the new can size (6 doses, 3 sprays per dose) by Q4 2015 /Q1 2016. Once the filing has been made the Company anticipates a 10 month Prescription Drug User Fee Act review with commercial launch in the US expected in 2017'.
Now adding the extra year for the change to the 12 dose canister, means we should have launched in 2018. Instead, we wont be launching till 2022', 4 years on and at an extra 6 mill USD in salary. And we wont even be launching with the 12 dose can, but the original 20 dose !!!
It is important to remember that the single most important market for sexual health products is the USA. If modelled on the revenue from erectile dysfunction drugs, this will account for 65% of global sales. The whole of the EU is likely to be 12-15%. That is why they are persevering with approval in the USA, despite many obstacles the FDA retrospectively introduced e.g. need for disease definition of PE and a validated PRO.
The Numan products should be seen in that context. The USA is the key value driver for Regent stock.
The most important factor is that there is absolutely no peer group reviewed clinical data to support the claims for their delay spray. In fact it looks like they are “borrowing” claims from the Fortacin label. That indeed was the case previously with Promescent that used our clinical data on their website until they were stopped with a “cease and desist” notice. The reason is that they don’t work or have obtrusive side effects particularly penile desensitisation.
In that context, their website would be illegal in the USA as this type of agent can be sold as a “monograph”product as a penile desensitiser and medical claims ‘’......for the treatment of......” are not allowed by FDA.
Saw an advert on UK tv. Company called NUMAN they where advertising services/treatment for ED . So I went on website they also offer treatment for PE. I spent through the consultation (obviously I had to lie) . At the end only offered prillgy as monthly treatment. Do they not know about fortacin? . Regent Pacific and recordati missed an opportunity here
agreed bignose.no obvious reason but hope continues
That’s about 3 days of some forward motion. Still Low volumes, but some positivity, however. I do wonder why ? It’s not like any news is due that would give the sp a good kickstart.
looked at the PRAC agenda for early june and nothing there. will look again at start of july.
well there i was looking at a down day so i popped outside to do a bit of gardening and lo and behold i came back in and we were up.this is my new investment strategy and i shall do the same tomorrow .dont suppose it will work twice though.lol
Keith, you are not wrong there given they have statements, some fraudulent, about entering the CBD market, having other pharma investments. Aiming to become one of the largest pharma investment vehicles in HK and will return shareholder value. Instead we have capital destruction, only one product which they seem to have no intrest in getting to market (the US timeline is a joke and constantly changing). What has happened to the US licenses that were in the final stages of being made all those years ago ? Its nothing but continued incompetence. But then again, if I were to be paid 1.5mill us dollars a year which I would lend back to the company with interest so they could pay me my salary, I wouldnt want to do much work either. I thought there was no such thing as perpetual motion ?
Well bignose, your question about 'what have they been doing?' is spot on....probably counting their salaries. I sometimes, actually constantly not sometimes, find it incredulous that a potentially good product can be reduced to such a litany of disasters. Ugh....
well bignose I'm not expecting good news I'm afraid,just hoping.my recollection is that we might get news re RX to OTC change by end of july but haven't checked so could are wrong.again I'm not expecting them to get it I'm afraid.
The.Italian, I too was expecting a few last minute sells, but surprisingly we received a few last minute buys. Still a long way to go though.
Although there is news expected, one can only go by previous history and not expect anything but bad news. China delayed, Recordati failure and HK/Macau delayed (I wonder what happens now given the current situation - This was one of the most wasteful and disastrous events, apart from the DBC) I wonder what Orient have actually achieved in the last 18 months ? And I wont even discuss the EU resubmission since they will probably **** that up too.
afternoon bignose.well i got that wrong.up a bit today.held up well but very low volume. i was waiting for the last minute sell to bring us back down at end but no didn't appear. some positive news would be nice. heres hopin!
Well. It certainly has held up so far (up 4% at this moment in time), even with the markets generally in the red doon. Lets see how things pan out when the fat lady sings at 16:00hrs... ;-)
Yup, I’m sure you are right. Doon again tmrw.. :)
well agree it certainly feels manipulated. one was almost waiting for the sell/sells to bring it back down at the end.but my question is what does it achieve? a bit of profit for traders i suppose but the amounts are so small it hardy seems worth it.perhaps theres nothing behind it at all.anyway at least we ended up a bit.no doubt down tomorrow to take us back to where we were.
Personally I feel its manipulation given that one minute there are many sells with no impact, then suddenly a single 10k sell with a 4+% drop.
It gets pushed up 30% for buys, then a few sells it comes crashing down. The automated matching system must have a bug....or an override button....honest gov, I slipped and my finger fell on the button. ;-)
its hard to explain.on the one hand £46k is about 0.3 % of the market cap, so perhaps a bigger % than it might seem when looking at the amount in isolation .still nothing like the % you would expect to produce a 30% swing in s/p. also so far as we know the only large shareolders are mellon and gibson so there must be a huge percentage in free float which to my mind makes the price movement even more unusual.so I've obviously no idea.
can anyone explain how this moves so much on such little volume??